# SaExten Vena Cava Filter System in Prevention of Pulmonary Embolism

Study · id `cardio:ct-nct04948502` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04948502](<https://clinicaltrials.gov/study/NCT04948502>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT04948502

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 192 participants.

## Technical summary

Registry record NCT04948502. Randomized; no masking; primary purpose prevention. Start 2020-08-13 (actual); primary completion 2022-01-20 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 192 participants (enrolled count; ClinicalTrials.gov record NCT04948502, source copy `cardio:ctgov-nct04948502-2023-09-29`, retrieved 2026-10-31)
- Started: 2020-08-13 (actual) (ClinicalTrials.gov record NCT04948502, source copy `cardio:ctgov-nct04948502-2023-09-29`, retrieved 2026-10-31)
- Primary completion: 2022-01-20 (actual) (ClinicalTrials.gov record NCT04948502, source copy `cardio:ctgov-nct04948502-2023-09-29`, retrieved 2026-10-31)
- Completion: 2022-09-08 (actual) (ClinicalTrials.gov record NCT04948502, source copy `cardio:ctgov-nct04948502-2023-09-29`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT04948502, source copy `cardio:ctgov-nct04948502-2023-09-29`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04948502-2023-09-29`, retrieved 2026-10-31)

## The registry's words

- Brief title: SaExten Vena Cava Filter System in Prevention of Pulmonary Embolism
- Condition: Pulmonary Embolism
- Intervention (Device): SaExten vena cava filter system
- Intervention (Device): Denali inferior vena cava filter
- Lead sponsor: ShenZhen KYD Biomedical Technology Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)

## Provenance

Content hash: 42c30d3cd5398b59cf6a37052f42dc8ccaf1edc1fc004c5891c0ac1636168ae5
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
